Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Recro Pharma, Inc.

REPH•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.09
$-0.01(-0.48%)
U.S. Market opens in 13h 57m

Recro Pharma, Inc. (REPH) Stock Overview

Explore Recro Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap177.4M
P/E Ratio-14.99
EPS (TTM)$-0.26
ROE-0.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

REPH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Recro Pharma, Inc. (REPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.99 and a market capitalization of 177.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
19.43%
3-Year Change
-88.55%
5-Year Change
-71.19%
All-Time (Max) Change
-71.92%

Contact Information

https://www.recrocdmo.com
14843952400
490 Lapp Rd, Malvern, PA, 19341

Company Facts

1,850 Employees
IPO DateMar 7, 2014
CountryUS

Frequently Asked Questions